Consistency evaluation of Liferiver, Yaneng, Darui, and the Cobas 4800 test for high‐risk human papillomavirus screening

BACKGROUND: In recent years, several high‐risk human papillomavirus (HR‐HPV) tests have been developed. The assay capabilities need to be systematically reviewed. Here, we compared the clinical sample performance of three novel HR‐HPV assays (Liferiver, Yaneng, and Darui) based on different platform...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mengmeng, Ji, Xiang, Dou, Xiaowen, Tang, Huamei, Kan, Lijuan, Wu, Wei, Chen, Dayang, Zong, Zengyan, Xiong, Dan, Zhang, Xiuming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755768/
https://www.ncbi.nlm.nih.gov/pubmed/32813301
http://dx.doi.org/10.1002/jcla.23536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755768/
https://www.ncbi.nlm.nih.gov/pubmed/32813301
http://dx.doi.org/10.1002/jcla.23536

Ejemplares similares